Topic Hub

Ethnicity Insulin Degludec

4 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

4articles

32keywords mapped

2026-05-27latest review

Explore

Ethnicity Insulin Degludec library

Showing 4 of 4 clinical reviews.

Questions2026-05-27

Tresiba (Insulin Degludec) Efficacy in Black / African Ancestry Patients: Documented Gaps and Clinical Guidance

Evidence review of insulin degludec (Tresiba) efficacy differences in Black and African ancestry populations, covering trial representation, HbA1c discordance, pharmacogenomic factors, and dosing considerations.

Read clinical review

Safety2026-05-27

Tresiba (Insulin Degludec) Safety Profile Differences in Black / African Ancestry Patients

Evidence-based review of insulin degludec (Tresiba) safety considerations for Black and African ancestry patients, including pharmacogenomic factors, cardiovascular outcomes from DEVOTE, and clinical monitoring recommendations.

Read clinical review

Dosing & Monitoring2025-01-15

Tresiba East Asian Documented Efficacy Gaps: Pharmacogenomics and Dosing Differences

Ethnicity-stratified trial data, pharmacogenomic evidence, and clinical dosing guidance for insulin degludec (Tresiba) in East Asian patients with type 1 and type 2 diabetes.

Read clinical review

Safety2025-01-15

Tresiba South Asian Safety Profile Differences: What Clinicians Need to Know

A detailed clinical review of insulin degludec (Tresiba) safety, pharmacokinetics, and dosing in South Asian patients, including ethnicity-stratified trial data, hypoglycemia risk, and cardiovascular considerations.

Read clinical review